Showing results 1 to 20 of 28
next >
| Issue Date | Title | Author(s) |
| 29-Jun-2021 | Analysis of Suspension of Clinical Trials for Drug Registration in China | Su, Xian; Pang, Xiaocong; Zeng, Xin; Gao, Yi; Cui, Yimin; Wang, Haixue |
| Mar-2023 | The challenges and opportunities of alpha v beta 3-based therapeutics in cancer: From bench to clinical trials | Gu, Yanlun; Dong, Bingqi; He, Xu; Qiu, Zhiwei; Zhang, Juqi; Zhang, Mo; Liu, Haitao; Pang, Xiaocong; Cui, Yimin |
| Nov-2021 | Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer | Zhang, Zhuo; Zhang, Hanxu; Li, Chao; Xiang, Qian; Xu, Ling; Liu, Qianxin; Pang, Xiaocong; Zhang, Wenjia; Zhang, Hong; Zhang, Shuang; Duan, Xuening; Liu, Yinhua; Cui, Yimin |
| 15-Sep-2021 | Co-expression and prognosis analyses of GLUT1-4 and RB1 in breast cancer | Zhang, Xiaodan; Pang, Xiaocong; Zhang, Zhuo; Liu, Qianxin; Zhang, Hanxu; Xiang, Qian; Cui, Yimin |
| 27-Apr-2020 | Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials | Zhang, Xiaodan; Xing, Lu; Jia, Xiaona; Pang, Xiaocong; Xiang, Qian; Zhao, Xia; Ma, Lingyue; Liu, Zhiyan; Hu, Kun; Wang, Zhe; Cui, Yimin |
| 2019 | Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in association with Metastasis Risk and Progression of Prostate Cancer | Pang, Xiaocong; Zhao, Ying; Wang, Jinhua; Li, Wan; Xiang, Qian; Zhang, Zhuo; Wu, Shiliang; Liu, Ailin; Du, Guanhua; Cui, Yimin |
| Jul-2023 | Discovery of a novel oral, non-RGD pan-αv integrin inhibitor for castration resistant prostate cancer treatment | Gu, Yanlun; Sun, Xiaojiao; Dong, Bingqi; Song, Song; Liu, Zhenming; Pang, Xiaocong; Cui, Yimin |
| 10-Feb-2023 | Discovery of C19-9 as a novel non-RGD inhibitor of alpha v beta 3 to overcome enzalutamide resistance in castration-resistant prostate cancer | Pang, Xiaocong; Sun, Xiaojiao; Gu, Yanlun; He, Xu; Gong, Kan; Song, Song; Zhang, Jixin; Xia, Jie; Liu, Zhenming; Cui, Yimin |
| 31-May-2021 | Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma | Li, Teng; Pang, Xiaocong; Wang, Junyun; Wang, Shouzheng; Guo, Yiying; He, Ning; Xing, Puyuan; Li, Junling |
| Jul-2023 | Identification of immune-related signatures and potential therapeutic drugs for pulmonary arterial hypertension | He, Xu; Pang, Xiaocong; Cui, Yimin |
| 10-Jul-2023 | Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis | He, Xu; Zhang, Juqi; Gong, Mingli; Gu, Yanlun; Dong, Bingqi; Pang, Xiaocong; Zhang, Chenglong; Cui, Yimin |
| 2019 | Identification of SPP1 as an Extracellular Matrix Signature for Metastatic Castration-Resistant Prostate Cancer | Pang, Xiaocong; Xie, Ran; Zhang, Zhuo; Liu, Qianxin; Wu, Shiliang; Cui, Yimin |
| May-2020 | Immune thrombocytopenia of haematological immune-related adverse events in cancer immunotherapy: Most and mighty | Pang, Xiaocong; Su, Xian; Zhang, Zhuo; Cui, Yimin |
| 18-Dec-2023 | Intranasal mask for protecting the respiratory tract against viral aerosols | Hu, Xiaoming; Wang, Shuang; Fu, Shaotong; Qin, Meng; Lyu, Chengliang; Ding, Zhaowen; Wang, Yan; Wang, Yishu; Wang, Dongshu; Zhu, Li; Jiang, Tao; Sun, Jing; Ding, Hui; Wu, Jie; Chang, Lingqian; Cui, Yimin; Pang, Xiaocong; Wang, Youchun; Huang, Weijin; Yang, Peidong; Wang, Limin; Ma, Guanghui; Wei, Wei |
| Mar-2024 | IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities | He, Xu; Wedn, Abdalla; Wang, Jian; Gu, Yanlun; Liu, Hongjin; Zhang, Juqi; Lin, Zhiqiang; Zhou, Renpeng; Pang, Xiaocong; Cui, Yimin |
| 15-May-2022 | LncRNA CRART16/miR-122-5p/FOS axis promotes angiogenesis of gastric cancer by upregulating VEGFD expression | Zhang, Junling; Pang, Xiaocong; Lei, Lili; Zhang, Jixin; Zhang, Xiaoqian; Chen, Ziyi; Zhu, Jing; Jiang, Yong; Chen, Guowei; Wu, Yingchao; Wu, Tao; Pan, Yisheng; Liu, Yucun; Cui, Yimin; Wang, Xin |
| 15-Jul-2021 | MiR-205-5p suppresses angiogenesis in gastric cancer by downregulating the expression of VEGFA and FGF1 | Zhang, Junling; Zhang, Jixin; Pang, Xiaocong; Chen, Ziyi; Zhang, Zhuo; Lei, Lili; Xu, Hongliang; Wen, Long; Zhu, Jing; Jiang, Yong; Cui, Yimin; Chen, Guowei; Wang, Xin |
| Jul-2023 | A novel anoikis-related subtype classification and risk signature for predicting biochemical recurrence and drug sensitivity in prostate cancer | Dong, Bingqi; Gu, Yanlun; Xie, Ran; He, Xu; Pang, Xiaocong; Wang, Xin; Cui, Yinmin |
| 5-May-2023 | A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer | Dong, Bingqi; Wu, Yingchao; Zhang, Junling; Gu, Yanlun; Xie, Ran; He, Xu; Pang, Xiaocong; Wang, Xin; Cui, Yimin |
| 2019 | Osteopontin as a multifaceted driver of bone metastasis and drug resistance | Pang, Xiaocong; Gong, Kan; Zhang, Xiaodan; Wu, Shiliang; Cui, Yimin; Qian, Bin-Zhi |
